Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. - Wikidata - awgldk - TriplyDB

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

http://www.wikidata.org/entity/Q35589524

about

Pathophysiology of diabetic retinopathy Medical management of diabetic retinopathy.The therapeutic effects of angiotensin-converting enzyme inhibitors in severe non-proliferative diabetic retinopathy Effect of angiotensin II type 1 receptor blocker and angiotensin converting enzyme inhibitor on the intraocular growth factors and their receptors in streptozotocin-induced diabetic rats.Human genetics of diabetic retinopathy: current perspectives.Vitreous levels of vascular endothelial growth factor in eyes with anterior hyaloidal fibrovascular proliferation.Characterisation of the vitreous proteome in proliferative diabetic retinopathy.Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy Pathogenesis of diabetic retinopathy and the renin-angiotensin system.Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy.O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells.PPARgamma Agonists: Potential as Therapeutics for Neovascular Retinopathies Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina.Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy.Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes.Pathologic Roles of Receptor-Associated Prorenin System in Idiopathic Epiretinal Membrane.Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.Proteomic analysis of ophthalmic disease.Trends in proteomic analysis of human vitreous humor samples.Therapeutic targets of renin-angiotensin system in ocular disorders.Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-(1-12) axis in the Pathogenesis of Diabetic Retinopathy.ARPE-19 cell growth and cell functions in euglycemic culture media.Many Faces of Renin-angiotensin System - Focus on Eye.(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation.Systemic oxygen therapy versus oral enalapril for treatment of diabetic macular ischemia: a randomized controlled trial.Characterization of Vitreous and Aqueous Proteome in Humans With Proliferative Diabetic Retinopathy and Its Clinical Correlation.Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction.Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.Plasma and aqueous humor angiotensin-converting enzyme levels in patients with diabetic retinopathy.(Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy.Proteome analysis of human vitreous proteins.Identification of angiotensin converting enzyme 2 in the rodent retina.Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.Receptor-associated prorenin system contributes to development of inflammation and angiogenesis in proliferative diabetic retinopathy.The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats.

P2860

Q26865897-229B255B-62AA-45F8-BDCA-DCC5E715790C Q33204062-3395BD67-4D4B-458B-B33F-3899281D9D7B Q33282849-1790A996-F79C-4D7B-B5DE-A3E3E582021F Q33914589-78092A7A-56C6-4AF9-9622-CA0B7269A358 Q34035397-FA2C9972-7109-4B27-B3CD-B05267549A0E Q34161125-74489771-ED14-4A27-8248-8FAA8FA0863B Q34184946-A2B71E11-61AC-40A5-97D8-1936815F8656 Q34356152-6E923843-8443-42A8-9456-5B86F008CEAF Q35586130-B2999C15-D2C3-41A3-8D47-098033F09BBF Q35592354-04A33408-079D-4C93-AD17-B8F06E0FC297 Q35739660-4029B207-3FE2-4E2E-8D01-44F365D274A9 Q35970441-1B557ED5-2277-4A2E-B73B-74EA9B6B7202 Q36676571-373DD819-7B9B-48E0-AF68-25A0EB2C6AF7 Q36803708-88184EA3-C7CA-4E23-810D-6867968DAD51 Q36807663-B1480A79-6633-47B4-B18C-8B35BFF5A1FF Q37071368-9D845D02-4DED-4314-8B10-0E74EE55679B Q37161400-9F5D0A35-00D9-43A8-A6C4-80E76FFEA516 Q37193753-78F82FFD-D276-400E-A91F-633B55371CA5 Q37690371-1D193DFC-E66F-42C1-B903-7B574962CFBA Q37864617-4EA1CF42-E6C5-403D-9C1B-34D8ED70D836 Q37991052-AEBEA364-EFB3-4063-BB0E-198317868238 Q38211623-3DEF072F-4DEB-4A4A-81F8-AD4A9B25622D Q39214578-54AA835B-13AA-4153-8936-6DFCA23FAB5B Q39238324-EB9B39A1-33BF-409A-AFAA-50C181D55370 Q40260039-2E93249D-28AF-4828-8C3E-6E5FF9C6F742 Q41015495-3E318DE1-7FCC-4CB3-82BA-688DABC62BE6 Q41275103-87E0F3E1-6FAA-490E-8499-3C332207B78B Q41466339-EF8AEF99-F9BE-4B0B-9D59-0169451F4CC4 Q41897708-9B70369B-771F-4915-85D8-711A15A0341C Q42098043-62D450C9-CD0E-4A91-A04E-56AB8813CD56 Q43106907-71AC29C2-F141-42B7-8DD0-D355F08851CD Q43107309-4DD29D3A-12BF-43E6-9870-CB06D9766AFB Q43797341-00CD6A56-6FF9-4A9B-B2F9-17E4350302D1 Q44585521-81589385-97FE-4C01-A039-846392E3CA39 Q46374769-9E49863B-C28F-48F0-A07C-38C350F7C044 Q46893249-97A7ECF0-18C0-4228-81B6-098E6E554ACB Q46899921-5A1F2F8A-43E9-4D54-A228-18CA2C4B4496 Q47115372-33171E02-F41A-4795-9C67-2FF4CFED0815 Q50947386-C0F97A11-3FAC-4243-8A02-9D9AB7877412 Q51034962-05C9CC57-7EAB-4D83-B14F-3E9FA2A2409B

P2860

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

http://www.wikidata.org/entity/Q35589524

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Angiotensin II and vascular en ...... ferative diabetic retinopathy.

@ast

Angiotensin II and vascular en ...... ferative diabetic retinopathy.

@en

type

label

Angiotensin II and vascular en ...... ferative diabetic retinopathy.

@ast

Angiotensin II and vascular en ...... ferative diabetic retinopathy.

@en

prefLabel

Angiotensin II and vascular en ...... ferative diabetic retinopathy.

@ast

Angiotensin II and vascular en ...... ferative diabetic retinopathy.

@en

P1433

Q35589524-5BED6600-022B-451E-80B3-172DB4CFB1A3

P1476

Q35589524-852D8009-DE19-4868-A1BA-A796D727F918

P2093

Q35589524-23DA645D-57EA-459F-BF1E-B3973109D1C6

Q35589524-65877999-5BD9-480A-B74E-1A2E374EFB81

Q35589524-B110BED5-B8D4-407E-BAA1-02254C9BD7BD

Q35589524-E9390098-E150-4920-BCC6-74FFE97D349E

P2860

Q35589524-0191827A-C099-45B0-A5DB-CF56EB5B738F

Q35589524-18558EED-B4E9-4812-AA19-DBF82A1D4C76

Q35589524-2B0F14B2-953A-44AA-AE36-EDE12B4DCFD6

Q35589524-4044B86D-98FE-4652-87C1-0B7824ED694F

Q35589524-41963C70-BCD6-4A1A-98F5-00D2F7E26D52

Q35589524-53DD0288-C376-4E4B-8027-9F772F4EABC5

Q35589524-5BEED957-2C6D-4EBE-84B2-3E1D49A5380E

Q35589524-72D6BFA0-AFEA-4EA9-9FC7-406D442CA6E2

Q35589524-94DB026C-488E-4235-BB77-203FAD8A58B3

Q35589524-D240202C-9CAD-4C91-BBC0-85F9848EFCA9

P304

Q35589524-62B6030F-6663-454F-A58B-C2928F455713

P31

Q35589524-D8A1770B-7A00-43C2-B1B1-2C850E40AD5E

P356

Q35589524-04331FBC-1AF2-49F9-B350-9FA21FC8468D

P407

Q35589524-B8FCF151-9462-49A8-BF7F-6FBB8C9FB9D5

P433

Q35589524-998B32FA-6F46-41EB-A21E-7FB99873B0E7

P478

Q35589524-55C45F68-C9B9-4AE3-B225-42CEC1C0B32E

P577

Q35589524-3DCE8316-EDD0-4B58-AA8A-222FA769E462

P5875

Q35589524-1452CD30-D989-48BF-81FA-59239A647C53

P698

Q35589524-C06EDA2F-453C-4C2B-9252-8FB48B064F92

P921

Q35589524-7573A99D-B7E1-4914-B1DC-ECBBA3737FA9

P932

Q35589524-40571A92-D97B-4CED-9092-C03654B910AC

P356

P1433

British Journal of Ophthalmology

P1476

Angiotensin II and vascular en ...... ferative diabetic retinopathy.

@en

P2093

Funatsu H

http://www.w3.org/2001/XMLSchema#string

Hori S

http://www.w3.org/2001/XMLSchema#string

Nakanishi Y

http://www.w3.org/2001/XMLSchema#string

Yamashita H

http://www.w3.org/2001/XMLSchema#string

P2860

Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group.

Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II.

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.

Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo.

Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells.

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.

P304

311-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.86.3.311

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277542646

http://www.w3.org/2001/XMLSchema#string

P698

11864890

http://www.w3.org/2001/XMLSchema#string

P921

P932

1771054

http://www.w3.org/2001/XMLSchema#string